ARTICLE | Company News
Amgen sales and marketing update
January 4, 2016 8:00 AM UTC
Germany's Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that Repatha evolocumab from Amgen provided “no hint of added benefit” over undisclosed comparator t...